Thursday, March 7, 2024

Why Follow The Threefold Rule For Publishing Anything In The Pharmaceutical Journal?

Pharmaceutical science covers is like a mash-up of all these cool subjects working together to make sure our meds do what they're supposed to do. At the end of the day, the goal of any pharmaceutical research is all about making our medicines even better. 

The primary criteria for pharmaceutical publication are threefold. These three publishing rules are originality, high scientific quality, and relevance to a multidisciplinary audience. Papers lacking sufficient experimental detail to substantiate their claims will not make the cut.

 

1.        Technical queries and editorial authority

 


If there are any technical queries regarding your submission, they will be directed back to you, the author. If your paper is accepted for publication in Pharmaceutical Journals, it cannot be published elsewhere in the same form, whether in the same or another language, without the consent of both the editors and the publisher.

 

2.     Authorship and approval

 

Manuscripts submitted with multiple authors at NMC (MCI) Approved Journals are reviewed under the assumption that all listed authors agree with the submission. It's also expected that a copy of the final manuscript has been approved by all authors and, implicitly or explicitly, by the responsible authorities in the labs where the research was conducted.

 

3.     Novelty and disclosure

 

When submitting your paper to Innovare Academic Sciences, it's essential to include a cover letter that outlines the novelty of your work or the approach taken in your research. Routine bioequivalence studies are less likely to be accepted, as the emphasis is on originality.

 

For more information, you can visit our website https://www.innovareacademics.in/ or call us at +919165136558

No comments:

Post a Comment

Can Any Researcher Publish In A Scopus Indexed Journal?

Scopus-indexed journals are the crème de la crème when it comes to any type of academic publishing in issues of quality and prestige. Season...